Page last updated: 2024-11-13

physalin g

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

physalin G: has immunosuppressive activity; from Physalis angulata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

physalin G : A physalin with antimalarial activity isolated from Physalis angulata. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
PhysalisgenusA plant genus of the family SOLANACEAE. Members contain physalin and withangulatin.[MeSH]SolanaceaeA plant family of the order SOLANALES, class MAGNOLIOPSIDA. Among the most noted are POTATOES; TOMATOES; CAPSICUM (green and red peppers); TOBACCO; and BELLADONNA.[MeSH]

Cross-References

ID SourceID
PubMed CID56683730
CHEMBL ID1835434
CHEBI ID69020
MeSH IDM0569684

Synonyms (4)

Synonym
physalin g
CHEMBL1835434
chebi:69020 ,
Q27137364
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antimalarialA drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
6alpha-hydroxy steroid
lactoneAny cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
organic heteroheptacyclic compound
physalinAny seco-steroid based on a 13,14-seco-16,24-cycloergostane skeleton and its substituted derivatives thereof. These phytochemicals form the major steroidal constituents of Physalis plants and exhibit antimicrobial and antiparasitic activity.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID1869148Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by CCK8 assay
AID623329Cytotoxicity against BALB/c mouse splenocytes assessed as [3H]thymidine incorporation after 24 hrs by beta counting2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Antimalarial activity of physalins B, D, F, and G.
AID1171138Antiinflammatory activity in Swiss Webster mouse assessed as reduction in paw edema at 100 mg/kg, ip dosed 40 mins before CFA injection and measured 2 to 6 hrs post CFA stimulus2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1171135Antiinflammatory activity in Swiss Webster mouse assessed as reduction in hyperalgesia at 100 mg/kg, ip dosed 40 mins before CFA injection and measured 2 to 6 hrs post CFA stimulus2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1171145Antinociceptive activity in Swiss Webster mouse assessed as increase in reaction time at 100 mg/kg, ip measured after 3 hrs by tail flick test2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1171125Antinociceptive activity in Swiss Webster mouse assessed as inhibition of formalin-induced early phase pain response at 50 mg/kg, ip dosed 40 mins before formalin injection2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1869149Antiproliferative activity against human SGC-7901 cells assessed as reduction in cell viability incubated for 48 hrs by CCK8 assay
AID1869152Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-stimulated NO production pretreated with LPS followed by compund addition by Griess reagent based microplate reader assay
AID623330Selectivity index, ratio of LC50 for mouse splenocytes to IC50 for chloroquine-resistant and mefloquine-sensitive Plasmodium falciparum W22011Journal of natural products, Oct-28, Volume: 74, Issue:10
Antimalarial activity of physalins B, D, F, and G.
AID1869147Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by CCK8 assay
AID623328Antimalarial activity against chloroquine-resistant and mefloquine-sensitive Plasmodium falciparum W2 infected in human O-positive erythrocytes assessed as inhibition of parasite growth by [3H]hypoxanthine incorporation assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Antimalarial activity of physalins B, D, F, and G.
AID1171129CNS toxicity in Swiss Webster mouse assessed as effect on motor performance at 100 mg/kg, ip after 40 mins by rotarod test2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1869153Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability incubated for 48 hrs by CCK8 assay
AID1171147Antinociceptive activity in Swiss Webster mouse assessed as increase in latency time at 100 mg/kg, ip measured after 0.5 to 2 hrs by hot plate test2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1869146Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by CCK8 assay
AID1171130CNS toxicity in Swiss Webster mouse assessed as effect on motor performance at 100 mg/kg, ip after 40 mins by open field test2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1171118Antinociceptive activity in Swiss Webster mouse assessed as inhibition of acetic acid-induced abdominal constrictions at 25 to 100 mg/kg, ip dosed 40 mins before acetic acid injection2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1171124Antinociceptive activity in Swiss Webster mouse assessed as inhibition of formalin-induced late phase pain response at 50 mg/kg, ip dosed 40 mins before formalin injection2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antinociceptive properties of physalins from Physalis angulata.
AID1869154Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 48 hrs by CCK8 assay
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.26 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]